Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity,...
Tech Stock News: Zymeworks (NASDAQ: $ZYME) Announces Participation in Upcoming Investor Conferences
Zymeworks Inc. (NYSE:ZYME – Get Rating) has received an average rating of “Hold” from the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among […]
Shares of Zymeworks Inc. (NYSE:ZYME – Get Rating) were down 4.5% on Monday . The company traded as low as $9.33 and last traded at $9.33. Approximately 134,863 shares traded hands during trading, a decline of 79% from the average daily volume of 641,867 shares. The stock had previously closed at $9.77. Wall Street Analyst […]
Zymeworks (NYSE:ZYME – Get Rating) had its target price boosted by Citigroup from $17.00 to $18.00 in a report issued on Thursday morning, The Fly reports. A number of other research analysts have also issued reports on the stock. Stifel Nicolaus boosted their price target on shares of Zymeworks from $18.00 to $19.00 in a […]